10/26/2013

GlysBy snc

Oral cancer risk assessment test

The first commercially available rapid test is now available to identify people at risk to develop oro-pharynx cancer in time.


HPV Ab test is the first test on the market able to detect antibodies against Human papilloma virus HPV 16, responsible for the 72% of the cases of oro- pharyngeal cancer onset in population at risk.


A simple test on finger tip blood or oral blood can identify on site people exposed to the virus and who have antibodies and should then be monitored during time to detect cancer at its very early stage.


Till now, oral cancer was only identified by the presence of oral abnormal cells or lesions so too late to prevent damages.


Now it will be possible to select risk patient and monitor in due time.


The product is CE marked and used by doctors, dentists, Oro- pharyngeal specialist and oncologists.


Contact us for more information or visit www.glysby.com , we are looking at distributors.